Rasha Aboelhassan: A New Ray of Hope for Stage III NSCLC with Neoadjuvant Immunotherapy
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared a post on LinkedIn:
“Remember that feeling when everything around you is dark and uncertain, with no sign of hope?
This is the same feeling experienced by patients with stage III non-small cell lung cancer (NSCLC), with borderline resectable disease, and inoperable disease.
They are not resectable, but at the same time, they are not as advanced as stage IV disease.
Recently, these patients have received a new ray of hope with neoadjuvant immunotherapy.
At the same time, EGFR mutation-positive patients will have great expectations with osimertinib according to NeoADAURA.”
Title: Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non–Small Cell Lung Cancer
Authors: Jianxing He, Masahiro Tsuboi, Walter Weder, Ke-Neng Chen, Maximilian J. Hochmair, Jin-Yuan Shih, Sung Yong Lee, Kang-Yun Lee, Nguyen Viet Nhung, Somcharoen Saeteng, Lunxu Liu, Ligang Xing, Nguyen Hoang Gia, Shuji Murakami, Yongtao Han, María Paz Saavedra, Seong Hoon Yoon, Carlos H.A. Teixeira, Carles Escriu, Alex Martinez-Marti, Collin M. Blakely, Yasushi Yatabe, Sanja Dacic, Yuri Rukazenkov, Xiangning Huang, Anupriya Dayal, Jamie E. Chaft
You can read the Full Article in the Journal of Clinical Oncology.
Title: Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non–Small Cell Lung Cancer
Authors: Biagio Ricciuti, Francesca Fusco, Alissa Cooper, Edoardo Garbo, Federica Pecci, Mihaela Aldea, Xinan Wang, Maria Mayoral Penalva, Michelle Ginsberg, Lynette M. Sholl, Mizuki Nishino, Alessandro Di Federico, Narek Shaverdian, Matthew Bott, Valentina Santo, Erino Rendina, Rocco Trisolini, Sara Ramella, Filippo Gallina, Enrico Melis, Simonetta Buglioni, Gabriele Minuti, Lorenza Landi, Paula A. Ugalde Figueroa, Alice T. Shaw, Jamie Chaft, Mark M. Awad, Federico Cappuzzo
You can read the Full Article in JAMA Oncology.
More posts featuring Rasha Aboelhassan.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023